Literature DB >> 22519520

Proteomic identification of in vivo interactors reveals novel function of skin cornification proteins.

Wilbert P Vermeij1, Bogdan I Florea, Sheena Isenia, A Alia, Jaap Brouwer, Claude Backendorf.   

Abstract

Protection against injurious external insults and loss of vital fluids is essential for life and is in all organisms, from bacteria to plants and humans, provided by some form of barrier. Members of the small proline-rich (SPRR) protein family are major components of the cornified cell envelope (CE), a structure responsible for the barrier properties of our skin. These proteins are efficient reactive oxygen species (ROS) quenchers involved not only in the establishment of the skin's barrier function but also in cell migration and wound healing. Here, a proteomic analysis of in vivo SPRR-interacting proteins confirmed their function in CE-formation and ROS-quenching and also revealed a novel unexpected role in DNA-binding. Direct in vitro and in vivo evidence proved that the DNA-binding capacity of SPRRs is regulated by the oxidation state of the proteins. At low ROS levels, nuclear SPRR is able to bind DNA and prevent ROS-induced DNA damage. When ROS levels increase, SPRR proteins multimerize and form an effective antioxidant barrier at the cell periphery, possibly to prevent the production or infiltration of ROS. At even higher ROS exposure, DNA-binding is restituted. A molecular model explaining how the intracellular oxidation state of SPRRs likely influences their selective protective function is provided.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22519520     DOI: 10.1021/pr300310b

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

Review 1.  Proline mechanisms of stress survival.

Authors:  Xinwen Liang; Lu Zhang; Sathish Kumar Natarajan; Donald F Becker
Journal:  Antioxid Redox Signal       Date:  2013-05-23       Impact factor: 8.401

2.  SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis.

Authors:  Susan Specht; Kumiko Isse; Isao Nozaki; John G Lunz; Anthony J Demetris
Journal:  Clin Exp Metastasis       Date:  2013-06-01       Impact factor: 5.150

3.  FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury.

Authors:  Monica Chang-Panesso; Farid F Kadyrov; Matthew Lalli; Haojia Wu; Shiyo Ikeda; Eirini Kefaloyianni; Mai M Abdelmageed; Andreas Herrlich; Akio Kobayashi; Benjamin D Humphreys
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

4.  Activation of Nrf2 in keratinocytes causes chloracne (MADISH)-like skin disease in mice.

Authors:  Matthias Schäfer; Ann-Helen Willrodt; Svitlana Kurinna; Andrea S Link; Hany Farwanah; Alexandra Geusau; Florian Gruber; Olivier Sorg; Aaron J Huebner; Dennis R Roop; Konrad Sandhoff; Jean-Hilaire Saurat; Erwin Tschachler; Marlon R Schneider; Lutz Langbein; Wilhelm Bloch; Hans-Dietmar Beer; Sabine Werner
Journal:  EMBO Mol Med       Date:  2014-02-06       Impact factor: 12.137

5.  The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline.

Authors:  Loren Pickart; Jessica Michelle Vasquez-Soltero; Anna Margolina
Journal:  Brain Sci       Date:  2017-02-15

6.  Mitotic catastrophe triggered in human cancer cells by the viral protein apoptin.

Authors:  H L Lanz; R M E Zimmerman; J Brouwer; M H M Noteborn; C Backendorf
Journal:  Cell Death Dis       Date:  2013-02-07       Impact factor: 8.469

7.  Quantitative proteomics reveals regulatory differences in the chondrocyte secretome from human medial and lateral femoral condyles in osteoarthritic patients.

Authors:  Johan Stenberg; Ulla Rüetschi; Eva Skiöldebrand; Johan Kärrholm; Anders Lindahl
Journal:  Proteome Sci       Date:  2013-10-04       Impact factor: 2.480

8.  GHK and DNA: resetting the human genome to health.

Authors:  Loren Pickart; Jessica Michelle Vasquez-Soltero; Anna Margolina
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.